Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Medical therapy of steroid-resistant Crohn's disease
Bruce E. Sands
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Medical therapy of steroid-resistant Crohn's disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Crohn's Disease
100%
Steroid Resistance
100%
Medical Therapy
100%
Initial Treatment
50%
Steroid Use
50%
Corticosteroids
25%
Corticosteroid Therapy
25%
Therapeutic Challenges
25%
6-mercaptopurine (6-MP)
25%
Cyclosporine
25%
Moderate to Severe
25%
Tacrolimus
25%
Effective Treatment
25%
Methotrexate
25%
Infliximab
25%
Mycophenolate Mofetil
25%
Thalidomide
25%
Repeated Treatment
25%
Secondary Failure
25%
Clear Distinction
25%
Steroid Responsiveness
25%
Dose-dependent
25%
Resistant Populations
25%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
100%
Steroids
100%
Corticosteroid
25%
Methotrexate
12%
Infliximab
12%
Azathioprine
12%
Mercaptopurine
12%
Ciclosporin
12%
Tacrolimus
12%
Thalidomide
12%
Mycophenolate Mofetil
12%
Diseases
12%